Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results

(TSX-V:ASG),(OTC US:ASAPF),(Other OTC:ASAPF), CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced it will file its financial results with SEDAR for the first quarter fiscal year 2025 ended March […]

KabaFusion Acquires Infusion Care Assets from Coram(R) to Expand its Nationwide Footprint of Patient-Focused Services

KabaFusion Acquires Infusion Care Assets from Coram(R) to Expand its Nationwide Footprint of Patient-Focused Services Expansion to Increase KabaFusion's Footprint to 32 Specialty Pharmacies and 19 Ambulatory Infusion Suites Across 26 States GlobeNewswire May 19, 2025 LEXINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) — KabaFusion, a nationally recognized leader in home and alternative site infusion,

Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results

Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results GlobeNewswire May 19, 2025 CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced it will file its

Blade Air Mobility to Present at the Ladenburg Thalmann Technology Innovation Expo 25

(NASDAQ:BLDE), NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) — Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), a technology-powered air mobility platform, today announced that Rob Wiesenthal, Chief Executive Officer, will present at Ladenburg Thalmann Technology Innovation Expo 25 on Wednesday, May 21, 2025 at 3:00pm ET. A webcast of the event will

Capital Bank Launches New Digital Banking Platform in Partnership with Q2, Advancing Innovation and Customer-Focused Growth

(NASDAQ:CBNK), ROCKVILLE, Md., May 19, 2025 (GLOBE NEWSWIRE) — Capital Bank, N.A. has officially launched its new digital banking platform, powered by Q2, a leader in digital transformation for financial services. The upgrade delivers a secure, modern experience for business customers and marks a major step in the Bank's ongoing digital evolution. Known for its

Blade Air Mobility to Present at the Ladenburg Thalmann Technology Innovation Expo 25

Blade Air Mobility to Present at the Ladenburg Thalmann Technology Innovation Expo 25 GlobeNewswire May 19, 2025 NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) — Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), a technology-powered air mobility platform, today announced that Rob Wiesenthal, Chief Executive Officer, will present at Ladenburg Thalmann Technology Innovation

Capital Bank Launches New Digital Banking Platform in Partnership with Q2, Advancing Innovation and Customer-Focused Growth

Capital Bank Launches New Digital Banking Platform in Partnership with Q2, Advancing Innovation and Customer-Focused Growth GlobeNewswire May 19, 2025 ROCKVILLE, Md., May 19, 2025 (GLOBE NEWSWIRE) — Capital Bank, N.A. has officially launched its new digital banking platform, powered by Q2, a leader in digital transformation for financial services. The upgrade delivers a secure,

SunCar Technology Reports First Quarter 2025 Results

SunCar Technology Group Inc. (the “Company” or “SunCar”) (NASDAQ: SDA), an innovative leader in cloud-based, software-focused B2B auto eInsurance and auto services in China, today reported first quarter 2025 financial results for the quarter ended March 31, 2025. First Quarter 2025 Highlights — Revenue for first quarter 2025 increased 20% to $102.6 million, compared to

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

(NasdaqGM:CLYM), WELLESLEY HILLS, Mass., May 19, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that the Company has granted an inducement equity award to a new employee, pursuant to the Company's 2025 Inducement Plan, as an inducement material to the new

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire May 19, 2025 WELLESLEY HILLS, Mass., May 19, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that the Company has granted an inducement equity award to a new employee, pursuant

Scroll to Top